Literature DB >> 28790726

GRAVES' DISEASE WITH WPW SYNDROME.

T K Jagadhish1.   

Abstract

Entities:  

Keywords:  Atrial fibrillation (AF); Thyrotoxicosis; WPW syndrome

Year:  2017        PMID： 28790726      PMCID： PMC5532113          DOI： 10.1016/S0377-1237(17)30185-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  10 in total

1.  Thyrotoxicosis, with ophthalmoplegia, myopathy, Wolff-Parkinson-White syndrome, and pericardial friction.

Authors:  J A STRONG
Journal:  Lancet       Date:  1949-06-04       Impact factor: 79.321

2.  Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway?

Authors:  O Fujimura; G J Klein; R Yee; A D Sharma
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.

Authors:  H J Wellens; D Durrer
Journal:  Am J Cardiol       Date:  1974-12       Impact factor: 2.778

4.  Ventricular fibrillation. A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome.

Authors:  L S Dreifus; R Haiat; Y Watanabe; J Arriaga; N Reitman
Journal:  Circulation       Date:  1971-04       Impact factor: 29.690

5.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.

Authors:  E Martino; M Safran; F Aghini-Lombardi; R Rajatanavin; M Lenziardi; M Fay; A Pacchiarotti; N Aronin; E Macchia; C Haffajee
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

6.  Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone.

Authors:  N Gondo; K Kumagai; K Matsuo; M Annoura; K Moroe; K Arakawa
Journal:  Cardiology       Date:  1994       Impact factor: 1.869

7.  Thyroid dysfunction during chronic amiodarone therapy.

Authors:  S G Albert; L E Alves; E P Rose
Journal:  J Am Coll Cardiol       Date:  1987-01       Impact factor: 24.094

8.  Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy.

Authors:  L N Horowitz; S R Spielman; A M Greenspan; G S Mintz; J Morganroth; R Brown; P M Brady; H R Kay
Journal:  J Am Coll Cardiol       Date:  1985-12       Impact factor: 24.094

9.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome.

Authors:  G J Klein; T M Bashore; T D Sellers; E L Pritchett; W M Smith; J J Gallagher
Journal:  N Engl J Med       Date:  1979-11-15       Impact factor: 91.245

10.  Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.

Authors:  T B Graboys; P J Podrid; B Lown
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.